Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

PACLITERO 30 SOLUTION FOR INJECTION 30MG/5ML - HSA Drug Approval Details

Approvals/HSA/PACLITERO 30 SOLUTION FOR INJECTION 30MG/5ML

Approved

THERAPEUTIC

PACLITERO 30 SOLUTION FOR INJECTION 30MG/5ML

HETERO LABS LIMITED (INDIA)🇸🇬 Health Sciences Authority

Approval Date: Mar 2, 2022
Approval ID: 77b4b758b2fa52fe
Company: HETERO LABS LIMITED (INDIA)
Type: Therapeutic

Approval Details

Approval Id: 77b4b758b2fa52fe
Drug Name: PACLITERO 30 SOLUTION FOR INJECTION 30MG/5ML
Product Name: PACLITERO 30 SOLUTION FOR INJECTION 30MG/5ML
Approval Number: SIN16435P
Approval Date: 2022-03-02
Registrant: HETERO SINGAPORE PTE. LTD.
Licence Holder: HETERO SINGAPORE PTE. LTD.
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: INJECTION, SOLUTION
Route Of Administration: INTRAVENOUS
Atc Code: L01CD01
Atc Item Name: paclitaxel
Pharma Manufacturer Name: HETERO SINGAPORE PTE. LTD.

Active Ingredients

Paclitaxel

30mg/5mL

PACLITAXEL

30 MG/5 ML

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Mar 2, 2022

Approval ID

77b4b758b2fa52fe

Type

Therapeutic

Back to HSA Approvals